| [1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1):7-30.
|
| [2] |
Yamashita S, Chun YS, Kopetz SE, et al. Biomarkers in colorectal liver metastases[J]. Br J Surg, 2018, 105(6): 618-627.
|
| [3] |
Batlle E, Clevers H. Cancer stem cells revisited[J]. Nat Med, 2017, 23(10):1124-1134.
|
| [4] |
Testa U, Pelosi E, Castelli G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells[J]. Med Sci, 2018, 6(2):E31.
|
| [5] |
Westphalen CB, Asfaha S, Hayakawa Y, et al. Long-lived intestinal tuft cells serve as colon cancer-initiating cells[J]. J Clin Invest, 2014, 124(3):1283-1295.
|
| [6] |
Boesch M, Reimer D, Rumpold H, et al. DyeCycle Violet used for side population detection is a substrate of P-glycoprotein[J]. Cytometry A, 2012, 81(6):517-522.
|
| [7] |
Leng Z, Yang Z, Li L, et al. A reliable method for the sorting and identification of ALDHhigh cancer stem cells by flow cytometry[J]. Exp Ther Med, 2017, 14(4):2801-2808.
|
| [8] |
Leng Z, Xia Q, Chen J, et al. Lgr5+CD44+EpCAM+ strictly defines cancer stem cells in human colorectal cancer[J]. Cell Physiol Biochem, 2018, 46(2):860-872.
|
| [9] |
O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[J]. Nature, 2007, 445(7123):106-110.
|
| [10] |
Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells[J]. Nature, 2007, 445(7123):111-115.
|
| [11] |
Sahlberg SH, Spiegelberg D, Glimelius B, et al. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells[J]. PLoS One, 2014, 9(4):e94621.
|
| [12] |
Ribeiro KB, da Silva Zanetti J, Ribeiro-Silva A, et al. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer[J]. Cancer Biomark, 2016, 16(4):513-521.
|
| [13] |
Dame MK, Attili D, McClintock SD, et al. Identification, isolation and characterization of human LGR5-positive colon adenoma cells[J]. Development, 2018, 145(6):dev153049.
|
| [14] |
Basu S, Haase G, Ben-Ze'ev A. Wnt signaling in cancer stem cells and colon cancer metastasis[J]. F1000Res, 2016(5): F1000 Faculty Rev-699.
|
| [15] |
Jiang S, Song C, Gu X, et al. Ubiquitin-specific peptidase 22 contributes to colorectal cancer stemness and chemoresistance via Wnt/β-catenin pathway[J]. Cell Physiol Biochem, 2018, 46(4): 1412-1422.
|
| [16] |
Jian Y, Wang M, Zhang Y, et al. Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer[J]. Cancer Lett, 2018(428):1-11.
|
| [17] |
Tóth C, Sükösd F, Valicsek E, et al. Loss of CDX2 gene expression is associated with DNA repair proteins and is a crucial member of the Wnt signaling pathway in liver metastasis of colorectal cancer[J]. Oncol Lett, 2018, 15(3):3586-3593.
|
| [18] |
Ohmori H, Fujii K, Kadochi Y, et al. Elaidic acid, a trans-fatty acid, enhances the metastasis of colorectal cancer cells[J]. Pathobiology, 2017, 84(3):144-151.
|
| [19] |
Fang C, Fan C, Wang C, et al. CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer[J]. Oncotarget, 2016, 7(47):77389-77403.
|
| [20] |
钮仕琦，张娜，刘昆等．结直肠癌干细胞相关标记物的研究进展[J/CD]．中华普通外科学文献（电子版），2018,12(3):213-216.
|